TITLE

Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor

AUTHOR(S)
Kaneko, Eizo; Hoshihara, Yoshio; Sakaki, Nobuhiro; Harasawa, Shigeru; Ashida, Kiyoshi; Asaka, Masahiro; Asaki, Shigeru; Nakamura, Takashi; Kobayashi, Kenzo; Kajiyama, Goro; Ogawa, Nobuya; Yao, Tsuneyoshi; Muto, Yasutoshi; Nakazawa, Saburo; Takemoto, Tadayoshi; Kaneko, E; Hoshihara, Y; Sakaki, N; Harasawa, S; Ashida, K
PUB. DATE
November 2000
SOURCE
Journal of Gastroenterology;2000, Vol. 35 Issue 11, p824
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
We investigated the peptic ulcer recurrence rates during maintenance therapy with H2-receptor antagonists (H2RAs) following first-line therapy with a proton pump inhibitor (PPI). Patients with gastric ulcer (GU) or duodenal ulcer (DU) were enrolled in this study; 583 eligible patients (GU, 325; DU, 258) were administered lansoprazole (30 mg/day for 8 weeks for GU, and the same dosage for 6 weeks for DU) as first-line therapy, and a half dose of H2RA as maintenance therapy for 12 months. Endoscopic photographs were taken before administration and after 8 (GU) and 6 (DU) weeks of lansoprazole administration. Ulcer stage was evaluated using the classification of Sakita and Miwa. Endoscopic examinations were performed 6 months or 12 months after the start of maintenance therapy or when a recurrence was suspected because of the appearance of subjective symptoms. The healing rates for GU and DU patients after completion of lansoprazole therapy were 79% in both groups, while the S2-stage healing rates were 18% and 31%, respectively. At 1 year after the start of maintenance therapy, the recurrence rates were 25% for GU and 39% for DU patients. In DU patients, the recurrence rates from S1-stage and S2-stage were 49% and 20%, respectively (P = 0.004), but no significant difference was found between these rates in GU patients. The recurrence rates in H. pylori-positive patients before lansoprazole administration were 27% for GU and 43% for DU patients. We concluded that the maintenance therapy with a half-dose of H2RA following PPI therapy was insufficient to prevent recurrences of GU and DU.
ACCESSION #
4690275

 

Related Articles

  • Pantoprazole for the Treatment of Peptic Ulcer Bleeding and Prevention of Rebleeding. van Rensburg, Christo J.; Cheer, Susan // Clinical Medicine Insights: Gastroenterology;2012, Issue 5, p51 

    Adding proton pump inhibitors (PPIs) to endoscopic therapy has become the mainstay of treatment for peptic ulcer bleeding, with current consensus guidelines recommending high-dose intravenous (IV) PPI therapy (IV bolus followed by continuous therapy). However, whether or not high-dose PPI...

  • Recurrent Peptic Ulcer due to Carcinoid Tumour of Jejunum. Bhattacharyya, Parimal // Indian Journal of Surgery;Aug2011, Vol. 73 Issue 4, p298 

    Carcinoid Tumours are classified as Neuro-endocrine tumours. Commonly known ulcerogenic neuro-endocrine tumour is Gastrinoma of the Pancreas and Duodenum.It secretes hormone Gastrin which causes hyperplasia of the gastric parietal cells with excessive secretion of hydrochloric acid resulting in...

  • Manage peptic ulcer disease in the elderly with proton pump inhibitors and additional measures as needed.  // Drugs & Therapy Perspectives;Mar2011, Vol. 27 Issue 3, p9 

    The rates of peptic ulcer-related hospitalization and mortality are high among elderly patients. Gastric acid suppression with proton pump inhibitors is the mainstay of treatment and should be used in combination with antibacterial agents for the eradication of Helicobacter pylori infection.

  • Helicobacter pylori Infection and Eradication in Paediatric Patients. Malaty, H.M. // Pediatric Drugs;Sep/Oct2000, Vol. 2 Issue 5, p357 

    Helicobacter pylori is now recognised to be typically acquired during childhood. Studies also indicate that the infection is frequently lost in childhood; however, it is still unclear whether this is related to the use of antibacterials, the natural history of the infection, or both. H. pylori...

  • Test for GERD Reveals That Many Are Taking Medications Unnecessarily.  // Women's Health Advisor;Sep2013, Vol. 17 Issue 9, p5 

    The article focuses on the increased inappropriate use of proton pump inhibitors (PPI) by people without being diagnosed with gastro esophageal reflux disease (GERD). It suggests for early diagnosis of GERD by esophageal power of hydrogen (Ph) monitoring following an endoscopy which helps to...

  • Proton Pump Inhibitors After Endoscopic Hemostasis in Patients With Peptic Ulcer Bleeding. Mesihovic, Rusmir; Vanis, Nenad; Mehmedovic, Amila; Gornjakovic, Srdjan; Gribajcevic, Mehmed // Medicinski Arhiv;2009, Vol. 63 Issue 6, p323 

    Background: Peptic ulcer bleeding is a common and potentially fatal condition. For patients with bleeding peptic ulcers that display major endoscopic stigmata of recent hemorrhage, a combination of endoscopic and pharmacologic therapy is the current standard management. Objective: To show our...

  • The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2 -receptor antagonist after bleeding from a gastric ulcer. Tatsuo Ozawa, Marisa; Nozomi Yoshikawa, Marisa; Takashige Tomita, Marisa; Yasushi Akita, Marisa; Keiji Mitamura // Journal of Gastroenterology;2003, Vol. 38 Issue 9, p844 

    Background. This study investigated the influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with intravenous infusions of proton pump inhibitors (PPIs) or with H2-receptor antagonists (H[sub2]-RAs) after bleeding from a gastric ulcer. Methods....

  • How Do PPIs Affect Patients with Bleeding Ulcers? Shaughnessy, Allen F. // American Family Physician;8/15/2005, Vol. 72 Issue 4, p683 

    Presents the results of a case study regarding the effectiveness of proton pump inhibitor (PPI) on patients with bleeding peptic ulcers. Factor which enhances platelet function and inhibit fibrolysis in patients with an acute bleeding peptic ulcer; Effect of PPI treatment on mortality rates...

  • Gastroduodenal posters.  // Gut;Apr2005 Supplement 2, Vol. 54, pA59 

    The article presents information on abstracts related to human biology. An abstract presents information on time trends in hospital admissions and mortality due to peptic ulcer in Scotland during 1991-2002. Despite the recent advent of potent acid suppressants and treatment for H. pylon...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics